The lymphoid chemokine, CXCL13, is dispensable for the initial recruitment of B cells to the acutely inflamed central nervous system

Brain, Behavior, and Immunity

Volumn 25, Issue 5, 2011, Pages 922-931

  Rainey Barger, Emily K ^a   Rumble, Julie M ^a   Lalor, Stephen J ^a   Esen, Nilufer ^a   Segal, Benjamin M ^a   Irani, David N ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Alphavirus encephalitis; B cell homing; Central nervous system; CXCL13; Experimental autoimmune encephalomyelitis

Indexed keywords

CD45 ANTIGEN; CXCL13 CHEMOKINE; CXCL9 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MYELIN; STROMAL CELL DERIVED FACTOR 1;

ALLERGIC ENCEPHALOMYELITIS; ALPHA VIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; ASTROCYTE; B LYMPHOCYTE; BRAIN TISSUE; CD4+ T LYMPHOCYTE; CELL COUNT; CELL INFILTRATION; CELL MIGRATION; CENTRAL NERVOUS SYSTEM; CLEARANCE; CONTROLLED STUDY; DEMYELINATING DISEASE; DISEASE COURSE; IMMUNE RESPONSE; LYMPHOID TISSUE; MICROGLIA; MOUSE; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; SYMPTOM; VIRUS ENCEPHALITIS; VIRUS REPLICATION;

ALPHAVIRUS INFECTIONS; ANIMALS; ASTROCYTES; B-LYMPHOCYTES; BRAIN; CELLS, CULTURED; CHEMOKINE CXCL13; CHEMOTAXIS, LEUKOCYTE; ENCEPHALITIS, VIRAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FLOW CYTOMETRY; MICE; MICE, INBRED C57BL; MICROGLIA; POLYMERASE CHAIN REACTION; SINDBIS VIRUS; TH1 CELLS; TH17 CELLS;

EID: 79957899037     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2010.10.002     Document Type: Article

References (51)

1. Allen C.D., Ansel K.M., Low C., Lesley R., Tamamura H., Fujii N., Cyster J.G. Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5. Nat. Immunol. 2004, 5:943-952.
2. Aloisi F., Columba-Cabezas S., Franciotta D., Rosicarelli B., Magliozzi R., Reynolds R., Ambrosini E., Coccia E., Salvetti M., Serafini B. Lymphoid chemokines in chronic neuroinflammation. J. Neuroimmunol. 2008, 198:106-112.
3. Ansel K.M., Ngo V.N., Hyman P.L., Luther S.A., Forster J.D., Sedgwick J.D., Browning J.L., Lipp M., Cyster J.G. A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature 2000, 406:309-314.
4. Ansel K.M., Harris R.B., Cyster J.G. CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity. Immunity 2002, 16:67-76.
5. Bagaeva L.V., Rao P., Powers J.M., Segal B.M. CXC chemokine ligand 13 plays a role in experimental autoimmune encephalomyelitis. J. Immunol. 2006, 176:7676-7685.
6. Campbell D.J., Kim C.H., Butcher E.C. Chemokines in the systemic organization of immunity. Immunol. Rev. 2003, 195:58-71.
7. Carson K.R., Evens A.M., Richey E.A., Haberman T.M., Focosi D., Seymour J.F., Laubach J., Bawn S.D., Gordon L.I., Winter J.N., Furman R.R., Vose J.M., Zelenetz A.D., Mamtani R., Raisch D.W., Dorshimer G.W., Rosen S.T., Muro K., Gottardi-Littell N.R., Talley R.L., Sartor O., Green D., Major E.O., Bennett C.L. Progressive multifocal leukoencephalopathy after rituximab in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project. Blood 2009, 113:4834-4840.
8. Chen S.C., Vassileva G., Kinsley D., Holzmann S., Manfra D., Wiekowski M.T., Romani N., Lira S.A. Ectopic expression of the murine chemokines CCL21a and CCL21b induces the formation of lymph node-like structures in pancreas, but not skin, of transgenic mice. J. Immunol. 2002, 168:1001-1008.
9. Columba-Cabezas S., Griguoli M., Rosicarelli B., Magliozzi R., Ria F., Serafini B., Aloisi F. Suppression of established experimental autoimmune encephalomyelitis and formation of meningeal lymphoid follicles by lymphotoxin β receptor-Ig fusion protein. J. Neuroimmunol. 2006, 179:76-86.
10. Dittel B.N., Urbania T.H., Janeway C.A. Relapsing and remitting experimental autoimmune encephalomyelitis in B cell deficient mice. J. Autoimmun. 2000, 14:311-318.
11. Esen N., Kielian T. Recognition of Staphylococcus aureus-derived peptidoglycan (PGN) but not intact bacteria is mediated by CD14 in microglia. J. Neuroimmunol. 2005, 170:93-104.
12. Fan L., Reilly C.R., Luo Y., Dorf M.E., Lo D. Cutting edge: ectopic expression of the chemokine TCA4/SLC is sufficient to trigger lymphoid neogenesis. J. Immunol. 2000, 164:3955-3959.
13. Fischer L., Korfel A., Pfeiffer S., Kiewe P., Volk H.D., Cakiroglu H., Widmann T., Thiel E. CXCL13 and CXCL12 in central nervous system lymphoma patients. Clin. Cancer Res. 2009, 15:5968-5973.
14. Forster R., Matis A.E., Kremmer E., Wolf E., Brem G., Lipp M. A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell 1996, 87:1037-1047.
15. Fu Y.-X., Chaplin D.D. Development and maturation of secondary lymphoid tissues. Annu. Rev. Immunol. 1999, 17:399-433.
16. Gea-Banacloche J.C. Rituximab-associated infections. Semin. Hematol. 2010, 47:187-198.
17. Griffin D., Levine B., Tyor W., Ubol S., Despres P. The role of antibody in recovery from alphavirus encephalitis. Immunol. Rev. 1997, 159:155-161.
18. Hauser S.L., Waubant E., Arnold D.L., Vollmer T., Fox R.J., Bar-Or A., Panzara M., Sarkar N., Agarwal S., Langer-Gould A., Smith C.H. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N. Engl. J. Med. 2008, 358:676-688. HERMES Trial Group.
19. Henry R.A., Kendall P.L. CXCL13 blockade disrupts B lymphocyte organization in tertiary lymphoid structures without altering B cell receptor bias or preventing diabetes in nonobese diabetic mice. J. Immunol. 2010, 185:1460-1465.
20. Hjelmstrom P. Lymphoid neogenesis: de novo formation of lymphoid tissue in chronic inflammation through expression of homing chemokines. J. Leukoc. Biol. 2001, 69:331-339.
21. Hjelmstrom P., Juedes A.E., Fjell J., Ruddle N.H. B cell-deficient mice develop experimental allergic encephalomyelitis with demyelination after myelin oligodendrocyte glycoprotein sensitization. J. Immunol. 1998, 161:4480-4483.
22. Krumbholz M., Theil D., Cepok S., Hemmer B., Kivisakk P., Ransohoff R.M., Hofbauer M., Farina C., Derfuss T., Hartle C., Newcombe J., Hohlfeld R., Meinl E. Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment. Brain 2006, 129:200-211.
23. Lalor S.J., Segal B.M. Lymphoid chemokines in the CNS. J. Neuroimmunol. 2010, 224:56-61.
24. Legler D.F., Loetscher M., Roos R.S., Clark-Lewis I., Baggiolini M., Moser B. B-cell attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5. J. Exp. Med. 1998, 187:655-660.
25. Levine B., Hardwick J.M., Trapp B.D., Crawford T.O., Bollinger R.C., Griffin D.E. Antibody-mediated clearance of alphavirus infection from neurons. Science 1991, 254:856-860.
26. Ljostad U., Mygland A. CSF B-lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis. J. Neurol. 2008, 255:732-737.
27. Luther S.A., Lopez T., Bai W., Hanahan D., Cyster J.G. BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-dependent lymphoid neogenesis. Immunity 2000, 12:471-481.
28. Luther S.A., Bidgol A., Hargreaves D.C., Schmidt A., Xu Y., Paniyadi J., Maloubian M., Cyster J.G. Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis. J. Immunol. 2002, 169:424-433.
29. Lyons J.A., San M., Happ M.P., Cross A.H. B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide. Eur. J. Immunol. 1999, 29:3432-3439.
30. Mackay F., Browning J.L. Turning off follicular dendritic cells. Nature 1998, 395:26-27.
31. Magliozzi R., Columba-Cabezas S., Serafini B., Aloisi F. Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis. J. Neuroimmunol. 2004, 148:11-23.
32. Magliozzi R., Howell O., Vora A., Serafini B., Nicholas R., Popolo M., Reynolds R., Aloisi F. Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain 2007, 130:1089-1104.
33. Martin A.P., Coronel E.C., Sano G., Chen S.C., Vassileva G., Canastro-Chibuque C., Sedgwick J.D., Frenette P.S., Lipp M., Furtado G.C., Lira S.A. A novel model for lymphocytic infiltration of the thyroid gland generated by transgenic expression of the CC chemokine CCL21. J. Immunol. 2004, 173:4791-4798.
34. Matsushita T., Yanaba K., Bouaziz J.-D., Fujimoto M., Tedder T.F. Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J. Clin. Invest. 2008, 118:3420-3430.
35. Mazzucchelli L., Blaser A., Kappeler A., Scharli P., Laissue J.A., Baggiolini M., Uguccioni M. BCA-1 is highly expressed in Helicobacter pylori-induced mucosa-associated lymphoid tissue and gastric lymphoma. J. Clin. Invest. 1999, 104:49-54.
36. Moench T.R., Griffin D.E. Immunocytochemical identification and quantification of the mononuclear cells in the cerebrospinal fluid, meninges, and brain during acute viral meningoencephalitis. J. Exp. Med. 1984, 159:77-88.
37. Moser B., Schaerli P., Laetscher P. CXCR5+ T cells: follicular homing takes center stage in T-helper-cell responses. Trends Immunol. 2002, 23:250-254.
38. Muller G., Hopken U.E., Lipp M. The impact of CCR7 and CXCR5 on lymphoid organ development and systemic immunity. Immunol. Rev. 2003, 195:117-135.
39. Ngo V.N., Korner H., Gunn M.D., Schmidt K.N., Riminton D.S., Cooper M.D., Browning J.L., Sedgwick J.D., Cyster J.G. Lymphotoxin-α/β and tumor necrosis factor are required for stromal cell expression of homing chemokines in B and T cell areas of the spleen. J. Exp. Med. 1999, 189:403-412.
40. Polman C.H., O'Connor P.W., Havrdova E., Hutchinson M., Kappos L., Miller D.H., Phillips J.T., Lublin F.D., Giovannoni G., Wajgt A., Toal M., Lynn F., Panzara M.A., Sandrock A.W., Investigators A.F.F.I.R.M. A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N. Engl. J. Med. 2006, 354:899-910.
41. Ransohoff R.M., Kivisakk P., Kidd G. Three or more routes for leukocyte migration into the central nervous system. Nat. Rev. Immunol. 2003, 3:569-581.
42. Rupprecht T.A., Plate A., Adam M., Wick M., Kastenbauer S., Schmidt C., Klein M., Pfister H.W., Koedel U. The chemokine CXCL13 is a key regulator of B cell recruitment to the cerebrospinal fluid in acute Lyme neuroborreliosis. J. Neuroinflamm. 2009, 6:42-51.
43. Sellebjerg F., Bornsen L., Khademi M., Krakauer M., Olsson T., Frederiksen J.L., Sorensen P.S. Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS. Neurology 2009, 73:2003-2010.
44. Serafini B., Rosicarelli B., Magiozzi R., Stigliano E., Aloisi F. Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. Brain Pathol. 2004, 14:164-174.
45. Stanley J., Cooper S.J., Griffin D.E. Monoclonal antibody cure and prophylaxis of lethal Sindbis virus encephalitis in mice. J. Virol. 1986, 58:107-115.
46. Tschen S.-I., Stohlman S.A., Ramakrishna C., Hinton D.R., Atkinson R.D., Bergmann C.C. CNS viral infection diverts homing of antibody-secreting cells from lymphoid organs to the CNS. Eur. J. Immunol. 2006, 36:603-612.
47. Tyor W.R., Griffin D.E. Virus specificity and isotype expression of intraparenchymal antibody-secreting cells during Sindbis virus encephalitis in mice. J. Neuroimmunol. 1993, 48:37-44.
48. Tyor W.R., Moench T.R., Griffin D.E. Characterization of the local and systemic B cell response of normal and athymic nude mice with Sindbis virus encephalitis. J. Neuroimmunol. 1989, 24:207-215.
49. Tyor W.R., Wesselingh S., Levine B., Griffin D.E. Long term intraparenchymal Ig secretion after acute viral encephalitis in mice. J. Immunol. 1992, 149:4016-4020.
50. Yoshie O., Imai T., Nomiyama H. Novel lymphocyte-specific CC chemokines and their receptors. J. Leukoc. Biol. 1997, 62:634-644.
51. Zlotnik A., Morales J., Hedrick J.A. Recent advances in chemokines and chemokine receptors. Crit. Rev. Immunol. 1999, 19:1-47.